Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 341–360 of 17,529 recalls

September 3, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Chlorpromazine Hydrochloride Tablets

The Issue: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 3, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Chlorpromazine Hydrochloride Tablets

The Issue: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 3, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Chlorpromazine Hydrochloride Tablets

The Issue: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 3, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Chlorpromazine Hydrochloride Tablets

The Issue: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 2, 2025· AvKARE

Recalled Item: Norgestimate and Ethinyl Estradiol Tablets

The Issue: Failed Content Uniformity Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 2, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Sulfamethoxazole and Trimethoprim

The Issue: Presence of a Foreign Substance: A specific lot

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 2, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Sulfamethoxazole and Trimethoprim

The Issue: Presence of a Foreign Substance: A specific lot

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 29, 2025· Fagron Compounding Services

Recalled Item: bevacizumab (Avastin) Injection

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 28, 2025· Green Lumber Holdings, LLC

Recalled Item: Green Lumber Natural Fuel For Men capsule

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
August 28, 2025· Granules Pharmaceuticals Inc.

Recalled Item: Dextroamphetamine Saccharate

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
August 28, 2025· Granules Pharmaceuticals Inc.

Recalled Item: Dextroamphetamine Saccharate

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
August 28, 2025· Granules Pharmaceuticals Inc.

Recalled Item: Dextroamphetamine Saccharate

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
August 28, 2025· Granules Pharmaceuticals Inc.

Recalled Item: Dextroamphetamine Saccharate

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
August 28, 2025· Granules Pharmaceuticals Inc.

Recalled Item: Dextroamphetamine Saccharate

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
August 28, 2025· Ascend Laboratories, LLC

Recalled Item: Aripiprazole Tablets

The Issue: Superpotent drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 27, 2025· DermaRite Industries, LLC

Recalled Item: Lantiseptic

The Issue: CGMP Deviation; manufactured at the same facility where

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 27, 2025· DermaRite Industries, LLC

Recalled Item: KleenFoam Antimicrobial Foam Soap

The Issue: CGMP Deviation; manufactured at the same facility where

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 27, 2025· DermaRite Industries, LLC

Recalled Item: DermaFungal

The Issue: CGMP Deviation; manufactured at the same facility where

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 27, 2025· DermaRite Industries, LLC

Recalled Item: DermaSarra

The Issue: CGMP Deviation; manufactured at the same facility where

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 27, 2025· DermaRite Industries, LLC

Recalled Item: PeriGiene

The Issue: CGMP Deviation; manufactured at the same facility where

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund